Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$772M |
| 2 |
Eli Lilly
LLY
|
+$337M |
| 3 |
lululemon athletica
LULU
|
+$301M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$297M |
| 5 |
ResMed
RMD
|
+$273M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$576M |
| 2 |
AT&T
T
|
+$476M |
| 3 |
PNC Financial Services
PNC
|
+$393M |
| 4 |
Fortive
FTV
|
+$389M |
| 5 |
Accenture
ACN
|
+$374M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 2.83% |
| 2 | Technology | 2.79% |
| 3 | Financials | 2.29% |
| 4 | Consumer Discretionary | 1.93% |
| 5 | Industrials | 1.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
7901
Navitas Semiconductor
NVTS
$3.44B
| $667K | ﹤0.01% |
172,874
+153,629
| +798% | +$1.06M |
|
|
WOW
7902
DELISTED
WideOpenWest
WOW
| $667K | ﹤0.01% |
36,633
+7,361
| +25% | +$148K |
|
7903
PUT
Jack Henry & Associates
JKHY
$11B
| $666K | ﹤0.01% |
3,700
-100
| -3% | -$18.7K |
|
7904
PUT
Mueller Industries
MLI
$14.2B
| $666K | ﹤0.01% |
50,000
+18,400
| +58% | +$249K |
|
|
Y
7905
PUT
DELISTED
Alleghany Corp
Y
| $666K | ﹤0.01% |
800
-2,900
| -78% | -$2.43M |
|
7906
Futu Holdings
FUTU
$15.2B
| $665K | ﹤0.01% |
+12,730
| New | +$480K |
|
7907
State Street SPDR S&P China ETF
GXC
$473M
| $665K | ﹤0.01% |
+7,245
| New | +$618K |
|
7908
CALL
Donaldson
DCI
$11B
| $664K | ﹤0.01% |
+13,800
| New | +$695K |
|
|
XRN
7909
PUT
Chiron Real Estate Inc
XRN
$484M
| $664K | ﹤0.01% |
11,820
+5,740
| +94% | +$387K |
|
7910
Goldman Sachs Access Ultra Short Bond ETF
GSST
$1.6B
| $663K | ﹤0.01% |
+13,300
| New | +$665K |
|
7911
PUT
ProShares Ultra QQQ
QLD
$14B
| $663K | ﹤0.01% |
32,000
-47,400
| -60% | -$1.24M |
|
7912
CALL
Broadstone Net Lease
BNL
$4.3B
| $662K | ﹤0.01% |
32,300
+5,200
| +19% | +$109K |
|
7913
SeaStar Medical
ICU
$13.2M
| $662K | ﹤0.01% |
261
+2
| +0.8% | +$5.07K |
|
|
CLVS
7914
PUT
DELISTED
Clovis Oncology, Inc.
CLVS
| $662K | ﹤0.01% |
367,600
+122,200
| +50% | +$180K |
|
7915
PUT
FerroAtlántica
GSM
$772M
| $661K | ﹤0.01% |
111,200
+42,200
| +61% | +$296K |
|
7916
Principal Exchange-Traded Funds Principal US Small-Cap ETF
PSC
$2.43B
| $660K | ﹤0.01% |
+17,334
| New | +$711K |
|
7917
PUT
Rambus
RMBS
$9.98B
| $660K | ﹤0.01% |
30,700
-4,900
| -14% | -$121K |
|
7918
Silicom
SILC
$259M
| $660K | ﹤0.01% |
19,626
-8,323
| -30% | -$296K |
|
7919
CALL
Telephone and Data Systems
TDS
$3.95B
| $660K | ﹤0.01% |
41,800
-6,300
| -13% | -$113K |
|
|
LICY
7920
CALL
DELISTED
Li-Cycle Holdings Corp.
LICY
| $660K | ﹤0.01% |
11,988
-10,512
| -47% | -$615K |
|
|
MNTV
7921
DELISTED
Momentive Global Inc. Common Stock
MNTV
| $660K | ﹤0.01% |
75,054
-21,539
| -22% | -$288K |
|
|
QMN
7922
DELISTED
IQ Hedge Market Neutral Tracker ETF
QMN
| $660K | ﹤0.01% |
26,411
-10,736
| -29% | -$274K |
|
|
ATXS
7923
DELISTED
Astria Therapeutics
ATXS
| $659K | ﹤0.01% |
219,962
-23,827
| -10% | -$107K |
|
7924
PUT
Cerus
CERS
$592M
| $659K | ﹤0.01% |
124,500
+109,200
| +714% | +$545K |
|
7925
Invesco Investment Grade Defensive ETF
IIGD
$26.8M
| $659K | ﹤0.01% |
27,079
-15,183
| -36% | -$372K |
|
Similar funds
Ken Griffin's Q2 2022 Portfolio in Review
As of Q2 2022, Ken Griffin held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Ken Griffin's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.
By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.
- Ken Griffin's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
- Ken Griffin added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
- Ken Griffin's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
- Ken Griffin fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
- Ken Griffin's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
- Ken Griffin opened 1,520 new positions and closed 2,191 in Q2 2022.
- Ken Griffin's portfolio value fell 20% quarter-over-quarter to $390B.
Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.